BAUPOST GROUP LLC 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-09 5:42 pm Sale |
2024-08-31 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 0 0.000% |
-2,977,304 (Position Closed) |
Filing |
| 2024-08-09 4:14 pm Sale |
2024-07-31 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 2,977,304 6.120% |
-4,441,922 (-59.87%) |
Filing |
| 2023-07-10 4:33 pm Sale |
2023-06-30 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 7,419,226 12.840% |
-4,000,000 (-35.03%) |
Filing |
| 2023-02-13 4:41 pm Sale |
2023-02-13 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 11,419,226 16.950% |
-3,111,770 (-21.41%) |
Filing |
| 2022-02-11 4:15 pm Purchase |
2022-02-11 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 14,530,996 19.490% |
4,925,000 (+51.27%) |
Filing |
| 2021-02-12 4:26 pm Sale |
2021-02-12 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 9,605,996 14.810% |
-574,000 (-5.64%) |
Filing |